Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Abbott |
---|---|
Information provided by: | Abbott |
ClinicalTrials.gov Identifier: | NCT00404391 |
The purpose of this study is to evaluate the effectiveness (level of pain control) and safety of the administration of 2 different dose levels of Extended Release Hydrocodone/Acetaminophen with placebo over a 48 hour dosing period in patients who have had bunionectomy surgery, and to assess the safety of the drug for 7 days after patients are discharged from the hospital.
Condition | Intervention | Phase |
---|---|---|
Pain |
Drug: Hydrocodone/Acetaminophen (Vicodin® CR) |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | A Randomized, Double-Blind, Placebo-Controlled Study Comparing the Analgesic Activity of Extended Release Hydrocodone/Acetaminophen (Vicodin® CR) and Placebo in Subjects With Pain Following Bunionectomy Surgery |
Estimated Enrollment: | 210 |
Study Start Date: | October 2003 |
Estimated Study Completion Date: | March 2004 |
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | M03-609 |
Study First Received: | November 26, 2006 |
Last Updated: | July 23, 2007 |
ClinicalTrials.gov Identifier: | NCT00404391 |
Health Authority: | United States: Food and Drug Administration |
Moderate to severe pain following bunionectomy surgery |
Naphazoline Oxymetazoline Guaifenesin Phenylephrine |
Hydrocodone Pain Phenylpropanolamine Acetaminophen |
Respiratory System Agents Physiological Effects of Drugs Central Nervous System Depressants Narcotics Pharmacologic Actions Analgesics, Non-Narcotic Sensory System Agents |
Therapeutic Uses Analgesics Peripheral Nervous System Agents Antitussive Agents Central Nervous System Agents Analgesics, Opioid |